image showing signpost with text saying we are here to support your evidence-based product generation

A fee-based consultancy service to developers of:

  • pharmaceuticals
  • biopharmaceuticals
  • medical devices
  • diagnostics

We work with you in the early stages of product development. Our mission is to encourage you to consider the relative clinical and cost effectiveness of your products. These considerations can then inform your development strategy.

Make an enquiry

 

Our advice helps you prepare for NICE evaluations and supports discussions with payers and commissioners to enable market access.

Engaging with scientific advice can:

  • help you develop evidence that demonstrates the value of your product
  • provide detailed feedback on your clinical, economic development and evidence generation plans
  • provide insights from NICE-appointed experts
  • advise on the advantages and disadvantages of different options
  • help to integrate cost-effectiveness considerations into your evidence generation plans
  • help companies understand health technology assessments, and the perspective of decision makers, at our educational seminars and events.

To find out more about our wide range of services, choose from one of the options below and read our frequently asked questions.

We can visit you to discuss the opportunities to engage with our programmes and services. Find out more about our site visits.

You can find out more about the team on our biographies page.

PReliminary Independent Model Advice – PRIMA 

PRIMA is a new NICE Scientific Advice service that offers an independent review of health economic models that have been developed in Excel or other specialist software.

PRIMA is a process which aims to improve the quality of economic models by providing expert advice on the model structure, data entry and transformations, computations, coding, usability and transparency.

For more information about this new service take a look at the PRIMA flyer and our frequently asked questions.


Image of a pill

Pharmaceutical products

Standard scientific advice

Detailed advice from NICE and a panel of appointed experts.

 

NICE-MHRA scientific advice

Joint regulatory advice from the Medicines and Healthcare products Regulatory Agency and NICE Scientific Advice.

 

HTA-EMA scientific advice

Advice from the European Medicines Agency in parallel with NICE and other European Health Technology Assessment bodies.

 

Advice for small and medium-sized companies

A concise, more affordable version of our standard advice process.

Read our FAQs
Image of a heart beat

Devices and diagnostics

Medtech Early Technical Assessment (META) tool

An affordable platform to help product developers understand what evidence is needed to make a convincing case to payers and commissioners for their technology.

 

Standard scientific advice

Detailed advice from NICE and a panel of appointed experts.

 

Advice for small and medium-sized companies

A concise, more affordable version of our standard advice process.

 

NICE-FDA scientific advice

Advice from the United States’ Food and Drug Administration PCTF in parallel with NICE. Contact us for further information.

Read our FAQs
Image of a seminar

Training and engagement

We offer a range of educational sessions, some are alongside internationally recognised consultancies. We can tailor these to your needs. These sessions provide regulatory and health technology assessment training for clients worldwide.

We also take part in external seminars and workshops, and often speak at or attend events.

More about seminars, site visits and events